Drug intelligence / Profile preview

multivitamin + l-lysine

Development stage
Unknown
Lead developer
Healthcare Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Lygen-V is an oral multivitamin and nutritional supplement developed and marketed by Healthcare Pharmaceuticals Ltd., a pharmaceutical company based in Bangladesh. The product is formulated as a tablet containing a combination of essential vitamins (A, D3, E, C, B1, B2, B6, B12, Nicotinamide, and Folic Acid) and the amino acid L-lysine. It is indicated for nutritional supplementation and the prevention of vitamin deficiencies in both children and adults. The inclusion of L-lysine is intended to improve appetite, promote growth in height and weight, support muscle protein synthesis, and aid in calcium absorption. As a nutritional supplement, Lygen-V functions by providing micronutrients that serve as essential cofactors for various metabolic processes and physiological functions, rather than acting on a specific molecular pharmacologic target.

Brand names
Lygen-VLysivin
Other names
Multivitamin + L-Lysine

Beyond the preview

Go deeper on multivitamin + l-lysine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on multivitamin + l-lysine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call